• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OUTSET MEDICAL, INC TABLO HEMODIALYSIS SYSTEM; HIGH PERMEABILITY HEMODIALYSIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OUTSET MEDICAL, INC TABLO HEMODIALYSIS SYSTEM; HIGH PERMEABILITY HEMODIALYSIS SYSTEM Back to Search Results
Model Number PN-0003000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Loss of consciousness (2418)
Event Date 04/10/2019
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr: the machine was evaluated at its location post treatment and was found to function as expected.Investigation of the device history record did not indicate any deviations or nonconformances during the manufacturing process.The log file review concluded events to be consistent with access issues.There was no indication that the device malfunctioned based on evaluations and feedback from hospital staff.The event is believed to be related to the patient's pre-existing conditions.
 
Event Description
It was reported that less than ten minutes into treatment, the patient lost consciousness.The patient started to desaturate into the low 80s, the heart rate rose into the 120s, while the blood pressure appeared to remain stable.Attempts made to wake the patient were unsuccessful and the patient remained unresponsive.The blood was rinsed back.It took the patient approximately five minutes to regain consciousness after the event occurred.The patient was placed back on a ventilator to help with oxygenation and his heart rate stabilized.It was reported that the patient is morbidly obese and very ill.The patient has a tunneled dialysis catheter in his chest; has a tracheostomy and was tachypneic prior to the dialysis treatment as he is recovering from acute respiratory failure and being on extracorporeal membrane oxygenation (ecmo).The patient had been on continuous renal replacement therapy (crrt) prior to this treatment.The patient was reported to be asymptomatic upon regaining consciousness (other than baseline tachypnea).The treating physician does not believe that the event was device related, rather, it was related to the patient's pre-existing conditions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TABLO HEMODIALYSIS SYSTEM
Type of Device
HIGH PERMEABILITY HEMODIALYSIS SYSTEM
Manufacturer (Section D)
OUTSET MEDICAL, INC
1830 bering drive
san jose CA 95112 4212
Manufacturer (Section G)
OUTSET MEDICAL, INC.
1830 bering drive
san jose CA 95112 4212
Manufacturer Contact
jennifer mascioli-tudor
1830 bering drive
san jose, CA 95112-4212
6692318235
MDR Report Key8688663
MDR Text Key147724150
Report Number3010355846-2019-00004
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00850001011112
UDI-Public(01)00850001011112(11)181227
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K160866
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/11/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPN-0003000
Device Catalogue NumberPN-0003000
Was Device Available for Evaluation? Yes
Date Manufacturer Received04/10/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/27/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age22 YR
-
-